
Springbok Analytics
AI-powered solutions providing the world’s most accurate, rapid and comprehensive insight and analysis of human muscle.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor investor investor investor | €0.0 | round | |
investor | €0.0 | round | |
* | $5.0m | Series A | |
Total Funding | 000k |
USD | 2021 | 2022 | 2023 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
% growth | - | 34 % | 107 % |
EBITDA | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Springbok Analytics is a pioneering company in the field of precision medicine, leveraging advanced AI-powered technology to provide detailed, objective data on muscle function. The company serves a diverse clientele including scientists, physical therapists, athletic trainers, and physicians. Operating within the healthcare and sports performance markets, Springbok Analytics offers a subscription-based business model, generating revenue through the sale of its analytics services and software. By providing insights into individual muscle performance, the company enables personalized training and rehabilitation programs, thereby reducing injury risks and optimizing recovery and performance. Key partnerships, such as those with Owens Recovery Science and Proactive Sports Performance, further enhance its offerings. The company has also secured significant investment, including a $4M award from the NFL to investigate hamstring injuries, underscoring its leadership in the industry.
Keywords: AI-powered, muscle analytics, precision medicine, injury prevention, performance optimization, rehabilitation, healthcare, sports performance, data-driven, personalized training.